Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C44H74O18 |
Molecular Weight | 891.0476 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 26 / 26 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@]5([H])C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@@](O)(CC[C@H](C)CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)O2)O[C@]7([H])O[C@H](CO[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@@H](O)[C@H](O)[C@H]7O
InChI
InChIKey=ISFAETRPBLFKQD-KTNFGKJSSA-N
InChI=1S/C44H74O18/c1-19(16-56-40-37(53)34(50)32(48)28(15-45)60-40)7-12-44(55)20(2)30-27(62-44)14-25-23-6-5-21-13-22(8-10-42(21,3)24(23)9-11-43(25,30)4)59-41-38(54)35(51)33(49)29(61-41)18-58-39-36(52)31(47)26(46)17-57-39/h19-41,45-55H,5-18H2,1-4H3/t19-,20-,21+,22-,23+,24-,25-,26+,27-,28+,29+,30-,31-,32+,33+,34-,35-,36+,37+,38+,39-,40+,41+,42-,43-,44+/m0/s1
Molecular Formula | C44H74O18 |
Molecular Weight | 891.0476 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 25 / 26 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:56:20 GMT 2023
by
admin
on
Sat Dec 16 10:56:20 GMT 2023
|
Record UNII |
35KP0AVB63
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
35KP0AVB63
Created by
admin on Sat Dec 16 10:56:20 GMT 2023 , Edited by admin on Sat Dec 16 10:56:20 GMT 2023
|
PRIMARY | |||
|
91864539
Created by
admin on Sat Dec 16 10:56:20 GMT 2023 , Edited by admin on Sat Dec 16 10:56:20 GMT 2023
|
PRIMARY | |||
|
187141-37-3
Created by
admin on Sat Dec 16 10:56:20 GMT 2023 , Edited by admin on Sat Dec 16 10:56:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
USP
|